PUNJABCHEM
Punjab Chemicals & Crop Protection share price & financials
- Price
- ₹1,042.8
- Market cap
- ₹1.3k Cr
- Sector
- Chemicals
- Calls analysed
- 4
Punjab Chemicals & Crop Protection Limited Q1 FY27
What went well
- Consolidated revenue from operations stood at INR 347.2 crores, a growth of 8.7% year-on-year.
- Gross margin improved to 36.6%, up 355 basis points on a yearly basis.
- EBITDA of INR 40.8 crores, reflecting growth of 18.8% year-on-year, with an EBITDA margin of 11.8%.
What to watch
- Indian agrochemical space is seeing a weak demand environment due to delayed sowing and weak monsoon, with visible pricing pressure.
- Supply chain remains fragile and sensitive to cost, with continuing volatility in raw material availability and logistics.
What Punjab Chemicals & Crop Protection Limited does
Punjab Chemicals and Crop Protection Limited manufactures complex-chemistry products across three synergistic divisions - Agrochemicals, Specialty Chemicals & Pharmaceuticals, and Industrial Chemicals - from facilities in Derabassi and Lalru (Punjab) and Pune (Maharashtra). It makes crop-protection molecules (herbicides, insecticides, fungicides), pharmaceutical intermediates, fine chemicals and APIs, and industrial chemicals such as food-grade phosphoric acid, and also acts as a contract development and manufacturing organisation (CDMO) for domestic and international agrochemical, pharma and specialty-chemical customers. It earns through a mix of proprietary product sales and long-term contract-manufacturing partnerships, exporting to Europe, Japan, North America and other markets.
Segments
- Agro Chemicals
- Specialty Chemicals & Pharmaceuticals
- Industrial Chemicals
- Manufacturing facilities
- 3 (Derabassi and Lalru, Punjab; Pune, Maharashtra)
- Total employees
- 1,230
- Reactor capacity
- Over 2,000 KL across multi-purpose production blocks
- Chemistries handled
- Capability to handle 40+ distinct chemistries
- New products commercialised
- 6-8 new products introduced every year
- R&D pipeline
- More than 25 products at R&D and pilot stage
Guidance record · Q1 FY27
what the last two calls moved 20 tracked 3 delivered 2 missed 15 open- Industrial Chemicals Revenue Growth went quiet said Q4 FY26 Promised: Doubling of sales in the next two years Q1 FY27: No specific update was provided on the performance or growth of the Industrial Chemicals division.
- Working Capital Cycle revised down said Q1 FY26 Promised: Improvement from 111 days in FY25 Q1 FY27: Management stated the working capital cycle is 'bit increasing' and will only return to 'last year's levels' by the end of FY27. This reverses the original promise of improvement.
- Greenfield Project Status on track said Q1 FY26 Promised: INR 250 crores over the next 3 years; scouting for the right opportunity. Q1 FY27: Management stated a clear goal to 'start the Greenfield capex in FY27'. This is consistent with the previously delayed timeline of announcing a site by Q2/Q3 FY27.
All 20 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 8.5%, net profit up 10.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 242 | 214 | 201 | 319 | 254 +5% | 246 +15% | 207 +3% | 346 +8% |
| EBITDA | 26 | 20 | 25 | 34 | 25 −4% | 29 +45% | 27 +8% | 41 +21% |
| Net profit | 12 | 7 | 7 | 20 | 17 +42% | 14 +100% | 10 +43% | 22 +10% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −3.8% 1Y
1Y: ₹1,107.8 on 10 Sept 2025 → ₹1,065.3. High ₹1,493.1 (31 Oct 2025), low ₹892.7 (30 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- −5.1%
- 31 Jul
- Q4 FY26
- −1.4%
- 5 May
- Q3 FY26
- +6.0%
- 29 Jan
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 0.7% a year over 3 years, FY23 to FY26. Operating margin narrowed to 11.2%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.0k Cr | ₹930 Cr | ₹899 Cr | ₹1.0k Cr |
| Operating profit | ₹122 Cr | ₹111 Cr | ₹99 Cr | ₹115 Cr |
| Operating margin | 12.1% | 11.9% | 11.0% | 11.2% |
| Interest | ₹18 Cr | ₹20 Cr | ₹18 Cr | ₹17 Cr |
| Depreciation | ₹20 Cr | ₹22 Cr | ₹24 Cr | ₹29 Cr |
| Net profit | ₹61 Cr | ₹55 Cr | ₹40 Cr | ₹61 Cr |
| Net margin | 6.1% | 5.9% | 4.4% | 5.9% |
| Cash from operations | ₹57 Cr | ₹29 Cr | ₹23 Cr | ₹99 Cr |
| Free cash flow | ₹21 Cr | ₹-2 Cr | ₹-8 Cr | ₹54 Cr |
| ROCE | 29.0% | 21.0% | 15.0% | 18.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| Reserves | ₹152 Cr | ₹229 Cr | ₹286 Cr | ₹336 Cr | ₹388 Cr | ₹431 Cr |
| Borrowings | ₹88 Cr | ₹93 Cr | ₹94 Cr | ₹123 Cr | ₹124 Cr | ₹154 Cr |
| Other liabilities | ₹219 Cr | ₹239 Cr | ₹242 Cr | ₹197 Cr | ₹169 Cr | ₹264 Cr |
| Total liabilities | ₹470 Cr | ₹574 Cr | ₹634 Cr | ₹669 Cr | ₹693 Cr | ₹861 Cr |
| Fixed assets | ₹189 Cr | ₹212 Cr | ₹222 Cr | ₹236 Cr | ₹259 Cr | ₹273 Cr |
| Capital work in progress | ₹16 Cr | ₹7 Cr | ₹20 Cr | ₹12 Cr | ₹14 Cr | ₹19 Cr |
| Investments | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹8 Cr | ₹4 Cr | ₹18 Cr |
| Other assets | ₹265 Cr | ₹354 Cr | ₹390 Cr | ₹413 Cr | ₹416 Cr | ₹551 Cr |
| Total assets | ₹470 Cr | ₹574 Cr | ₹634 Cr | ₹669 Cr | ₹693 Cr | ₹861 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public trimmed −2.97 pp while FIIs added +2.87 pp. The shareholder count shrank 4% to 19,497.
- Promoters
- 39.2%
- FIIs
- 5.9%
- DIIs
- 0.6%
- Public
- 54.3%
Since Jun 2025
- Public −2.97 pp
- FIIs +2.87 pp
- DIIs +0.09 pp
How it drifted, 12 quarters
Over this window the public fell from 57.6% to 54.3% — −3.4 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 39.2%, FIIs 3.0%, DIIs 0.1%, Public 57.6%.Dec '23: Promoters 39.2%, FIIs 3.0%, DIIs 0.1%, Public 57.6%.Mar '24: Promoters 39.2%, FIIs 3.0%, DIIs 0.4%, Public 57.4%.Jun '24: Promoters 39.2%, FIIs 3.0%, DIIs 0.4%, Public 57.3%.Sep '24: Promoters 39.2%, FIIs 3.0%, DIIs 0.4%, Public 57.4%.Dec '24: Promoters 39.2%, FIIs 2.9%, DIIs 0.5%, Public 57.3%.Mar '25: Promoters 39.2%, FIIs 3.1%, DIIs 0.6%, Public 57.2%.Jun '25: Promoters 39.2%, FIIs 3.0%, DIIs 0.6%, Public 57.3%.Sep '25: Promoters 39.2%, FIIs 3.0%, DIIs 0.6%, Public 57.2%.Dec '25: Promoters 39.2%, FIIs 3.0%, DIIs 0.6%, Public 57.2%.Mar '26: Promoters 39.2%, FIIs 3.0%, DIIs 0.6%, Public 57.1%.Jun '26: Promoters 39.2%, FIIs 5.9%, DIIs 0.6%, Public 54.3%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Ares Diversified AIF newly disclosed 3.43% held
The same filing shows 2 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Punjab Chemicals & Crop Protection Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Hemsil Trading and Manufacturing Pvt. Ltd. | 32.76% | unchanged |
| Gowal Consulting Services Private Limited | 21.04% | −3.43 pp |
| Excel Industries Limited | 4.77% | unchanged |
| Ares Diversified AIF | 3.43% | newly disclosed |
| Arial Holdings 1 FPI fund | 2.02% | −0.56 pp |
| Shalil ShashiKumar Shroff | 1.88% | unchanged |
| Hemal Raju Shete | 1.74% | unchanged |
| Rupam Shalil Shroff | 1.69% | unchanged |
| Salil ShashiKumar Shroff HUF | 0.63% | unchanged |
| Malvika Shalil Shroff | 0.29% | unchanged |
| Ishika Shalil Shroff | 0.25% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
Growth trapTo justify its price of ₹1065, this stock must grow earnings at 15% every year for 7 years. Our analysis caps realistic growth at ~-3%. At that growth it is worth ₹421 — downside of 61%.
- Growth the price implies
- 14.5% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -2.8% a year
- net profit, FY23–FY26 · EPS -2.7%
- The gap
- 0.2 pp
- -61% downside if it only repeats history
All earnings calls (4)
Read the Q1 FY27 call →Learn to analyse Punjab Chemicals & Crop Protection Limited
Guides on how to read this kind of business and the numbers that matter.